» Articles » PMID: 39769104

Immune and Metabolic Mechanisms of Endothelial Dysfunction

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2025 Jan 8
PMID 39769104
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial dysfunction is a strong prognostic factor in predicting the development of cardiovascular diseases. Dysfunctional endothelium loses its homeostatic ability to regulate vascular tone and prevent overactivation of inflammation, leading to vascular dysfunction. These functions are critical for vascular homeostasis and arterial pressure control, the disruption of which may lead to hypertension. Hypertension itself can also cause endothelial dysfunction, as endothelial cells are susceptible to haemodynamic changes. Although it is unclear which of those factors appear first, they create a vicious circle further damaging multiple organs, including the heart and vessels. There are also sex-specific differences in homeostatic functions of the endothelium regarding vessel tone regulation, which may contribute to differences in arterial blood pressure between men and women. Even more importantly, there are sex-differences in the development of endothelial dysfunction and vessel remodelling. Hence, an understanding of the mechanisms of endothelial dysfunction and its contribution to pathological vascular remodelling during hypertension is of critical importance. This review addresses immunological and metabolic aspects in mechanisms of endothelial dysfunction and the resulting mechanisms in vascular remodelling with respect to arterial hypertension, including the potential role of sex-specific differences.

References
1.
Govers R, Rabelink T . Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol. 2001; 280(2):F193-206. DOI: 10.1152/ajprenal.2001.280.2.F193. View

2.
Andreozzi F, Laratta E, Sciacqua A, Perticone F, Sesti G . Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circ Res. 2004; 94(9):1211-8. DOI: 10.1161/01.RES.0000126501.34994.96. View

3.
Taguchi K, Kobayashi T, Takenouchi Y, Matsumoto T, Kamata K . Angiotensin II causes endothelial dysfunction via the GRK2/Akt/eNOS pathway in aortas from a murine type 2 diabetic model. Pharmacol Res. 2011; 64(5):535-46. DOI: 10.1016/j.phrs.2011.05.001. View

4.
Zhang X, Leng S, Liu X, Hu X, Liu Y, Li X . Ion channel Piezo1 activation aggravates the endothelial dysfunction under a high glucose environment. Cardiovasc Diabetol. 2024; 23(1):150. PMC: 11067304. DOI: 10.1186/s12933-024-02238-7. View

5.
Lemarie C, Tharaux P, Lehoux S . Extracellular matrix alterations in hypertensive vascular remodeling. J Mol Cell Cardiol. 2009; 48(3):433-9. DOI: 10.1016/j.yjmcc.2009.09.018. View